Brilakis ES, Young WF J., Wilson JW et al (1999) Reversible catecholamineinduced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension. J Heart Lung Transplant 18:376–380
Article
CAS
PubMed
Google Scholar
Dinckal MH, Davutoglu V, Soydinc S et al (2003) Phaeochromocytoma-induced myocarditis mimicking acute myocardial infarction. Int J Clin Pract 57:842–843
CAS
PubMed
Google Scholar
Farroni JA (2005) Pheochromocytoma presenting as heart failure. Prog Cardiovasc Nurs 20:117–119
Article
PubMed
Google Scholar
Gatzoulis KA, Tolis G, Theopistou A et al (1998) Cardiomyopathy due to a pheochromocytoma. A reversible entity. Acta Cardiol 53:227–229
CAS
PubMed
Google Scholar
Imperadore F, Azzolini M, Piscioli F et al (2002) A rare cause of cardiogenic shock: catecholamine cardiomyopathy of pheochromocytoma. Ital Heart J 3:375–378
PubMed
Google Scholar
Kloner RA, Jennings RB (2001) Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 104:2981–2989
Article
CAS
PubMed
Google Scholar
Quigg RJ, Om A (1994) Reversal of severe cardiac systolic dysfunction caused by pheochromocytoma in a heart transplant candidate. J Heart Lung Transplant 13:525–532
CAS
PubMed
Google Scholar
Shub C, Cueto-Garcia L, Sheps SG et al (1986) Echocardiographic findings in pheochromocytoma. Am J Cardiol 57:971–975
Article
CAS
PubMed
Google Scholar
Simons M, Downing SE (1985) Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J 109:297–304
Article
CAS
PubMed
Google Scholar
Singh K, Xiao L, Remondino A et al (2001) Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189:257–265
Article
CAS
PubMed
Google Scholar
Stenstrom G, Holmberg S (1985) Cardiomyopathy in phaeochromocytoma: report of a case with a 16-year follow- up after surgery and review of the literature. Eur Heart J 6:539–544
CAS
PubMed
Google Scholar